The FDA announced on April 23, 2015, that Hospira Inc. is recalling Bupivacaine Hydrochloride Injections due to the presence of iron oxide particles. The agency classified the recall as Class I.
How to tell if you have it
- Brand: Hospira
- Product: Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL Single Use Vials, Rx only
- NDC: 0409-1162-02
- Lot #: 38-515-DK
- Expiry: 1 FEB 2016
The hazard
The recall addresses the presence of free-floating and embedded iron oxide particles in the product. The FDA listed this as a Class I hazard.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include Asteria Health ESTRADIOL 20mg Pellet Recall (Jan. 26, 2026), Taro Recalls Children's Ibuprofen Due to Foreign Substance (March 2, 2026), and Asteria Health ESTRADIOL Pellets Recall (Jan. 26, 2026).